approval · primary record
INSULIN DEGLUDEC
FDA · BLA · 2025-10-14
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-10-14 |
| Brand | XULTOPHY 100/3.6 |
| Sponsor | NOVO |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:14.534Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:INSULIN DEGLUDEC:2025-10-14
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.